REGENXBIO, Inc. (RGNX)
8.64
-0.08
(-0.92%)
USD |
NASDAQ |
Mar 06, 16:00
10.15
+1.51
(+17.48%)
After-Hours: 20:00
REGENXBIO Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Sarepta Therapeutics, Inc. | 69.64M |
| AbbVie, Inc. | -6.643B |
| BioMarin Pharmaceutical, Inc. | -414.24M |
| Altimmune, Inc. | -- |
| Omeros Corp. | 87.93M |